Y-Intercept (HK)
MRNA icon

Y-Intercept (HK)’s Moderna MRNA Stock Holding History

Y-Intercept (HK)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.3M Sell
58,588
-81,273
-58% -$8.76M 0.25% 67
2026
Q2 		$9.8M Buy
139,861
+123,351
+747% +$6.38M 0.19% 95
2026
Q1 		$839K Sell
16,510
-444,343
-96% -$20.7M 0.02% 1096
2025
Q4 		$13.6M Buy
+460,853
New +$12.5M 0.3% 39
2025
Q3 		– Sell
-102,800
Closed -$2.84M – 1862
2025
Q2 		$2.84M Buy
+102,800
New +$2.71M 0.07% 444
2025
Q1 		– Sell
-74,409
Closed -$3.09M – 1468
2024
Q4 		$3.09M Sell
74,409
-26,750
-26% -$1.28M 0.21% 121
2024
Q3 		$6.76M Buy
101,159
+23,881
+31% +$2.19M 0.41% 24
2024
Q2 		$9.18M Buy
+77,278
New +$9.8M 0.5% 17
2023
Q4 		– Sell
-2,143
Closed -$221K – 1494
2023
Q3 		$221K Buy
+2,143
New +$239K 0.02% 879
2023
Q1 		– Sell
-12,094
Closed -$2.17M – 1406
2022
Q4 		$2.17M Buy
+12,094
New +$1.98M 0.32% 46
2022
Q3 		– Sell
-8,640
Closed -$1.23M – 1162
2022
Q2 		$1.23M Buy
+8,640
New +$1.23M 0.16% 177
2022
Q1 		– Sell
-1,106
Closed -$281K – 865
2021
Q4 		$281K Buy
+1,106
New +$323K 0.07% 416
2021
Q3 		– Sell
-38,178
Closed -$8.97M – 819
2021
Q2 		$8.97M Buy
38,178
+33,295
+682% +$5.95M 2.28% 2
2021
Q1 		$579K Sell
4,883
-15,648
-76% -$2.27M 0.16% 213
2020
Q4 		$2.28M Buy
+20,531
New +$2.08M 0.96% 6

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures, LLc
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Patton Fund Management
Patton Fund Management Dallas, Texas $389M AUM 65.14% 1-Year Est. Return

Y-Intercept (HK)'s MRNA Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Moderna (MRNA) stake by 58% in Q3 2026, selling an estimated $8.76M and leaving 58,588 shares worth $11.3M. The position accounts for 0.25% of the portfolio, ranked #67.

Y-Intercept (HK) first reported a position in MRNA in Q4 2020 and has held it in 15 quarters since. The position peaked at $13.6M in Q4 2025. 198 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Y-Intercept (HK) held 58,588 shares of Moderna worth $11.3M as of Q3 2026.
  • Y-Intercept (HK) sold 81,273 Moderna shares in Q3 2026, an estimated $8.76M.
  • Moderna made up 0.25% of Y-Intercept (HK)'s portfolio in Q3 2026, its #67 holding.
  • Y-Intercept (HK) first reported a position in Moderna in Q4 2020 and has held it in 15 quarters since.
  • Y-Intercept (HK)'s Moderna position peaked at $13.6M in Q4 2025.
  • 198 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.